FDA Outlines Agenda For Cybersecurity Workshop
This article was originally published in The Gray Sheet
Executive Summary
Topics that will be addressed at an upcoming FDA cybersecurity meeting include postmarket management, risk assessment, the challenges of collaboration and developing cybersecurity standards.
You may also be interested in...
FDA Says It Is Changing Its Cybersecurity Culture, And Others Should Too
Speaking at the 2015 mHealth Summit, Suzanne Schwartz, the FDA device center's top cybersecurity expert, said the agency is undergoing a cultural shift to better deal with device cybersecurity vulnerabilities and urged manufacturers, security researchers and hospitals to do the same.
FDA Cybersecurity Efforts Emphasize Collaboration With Homeland Security Officials, Hospitals
CDRH’s emergency preparedness director spelled out the device center’s cybersecurity efforts during a recent webinar. The efforts go beyond guidance and regulations and include proactive steps to tackle the challenge, including weekly meetings with the Department of Homeland Security, she said.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.